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ABSTRACT
Purpose The ‘Oxford Pain, Activity and Lifestyle’ (OPAL) 
Cohort is a longitudinal, prospective cohort study of adults, 
aged 65 years and older, living in the community which is 
investigating the determinants of health in later life. Our 
focus was on musculoskeletal pain and mobility, but the 
cohort is designed with flexibility to include new elements 
over time. This paper describes the study design, data 
collection and baseline characteristics of participants. 
We also compared the OPAL baseline characteristics with 
nationally representative data sources.
Participants We randomly selected eligible participants 
from two stratified age bands (65–74 and 75 and over 
years). In total, 5409 individuals (42.1% of eligible 
participants) from 35 general practices in England agreed 
to participate between 2016 and 2018. The majority of 
participants (n=5367) also consented for research team to 
access their UK National Health Service (NHS) Digital and 
primary healthcare records.
Findings to date Mean participant age was 74.9 years 
(range 65–100); 51.5% (n=2784/5409) were women. 
94.9% of participants were white, and 28.8% lived alone. 
Over 83.0% reported pain in at least one body area in the 
previous 6 weeks. Musculoskeletal symptoms were more 
prevalent in women (86.4%). One- third of participants 
reported having one or more falls in the last year. Most 
participants were confident in their ability to walk outside. 
The characteristics of OPAL Cohort participants were 
broadly similar to the general population of the same age.
Future plans Postal follow- up of the cohort is being 
undertaken at annual intervals, with data collection 
ongoing. Linkage to NHS hospital admission data is 
planned. This English prospective cohort offers a large and 
rich resource for research on the longitudinal associations 
between demographic, clinical, and social factors and 
health trajectories and outcomes in community- dwelling 
older people.
INTRODUCTION
The population of the UK is undergoing 
a fundamental change in its age structure, 
due to lower birth rates and extended life 
expectancy. One in four people in the UK are 
projected to be aged 65 or over by 2050, with 
15% aged over 75 years and 5% aged 85 years 
or older.1 This change reflects gains in health 
and social development, and it is important 
that as many years of life are spent in good 
health as possible.
Active independence is one of the key 
concerns of older people, and mobility is 
critically important for independence.2 3 
Older people value their mobility highly and 
consider mobility loss as a key disadvantage 
of ageing.4 Poor or limited mobility is linked 
to functional decline, mortality and increased 
healthcare utilisation.5 Conceptually, factors 
associated with mobility decline precede 
disability within models of disablement. 
Therefore, identification of factors associated 
with mobility decline is important for preven-
tion of, and rehabilitation from, mobility 
decline.6
Musculoskeletal pain is one of the leading 
causes of disability and disease burden world-
wide among community- dwelling older 
adults.7 8 A recent review estimated that the 
Strengths and limitations of this study
 ► Oxford Pain, Activity and Lifestyle (OPAL) is a new, 
high- quality cohort of older community- dwelling 
people aiming to explore causes and consequences 
of pain, frailty, mobility decline, disability and poor 
health- related quality of life.
 ► A total of 5409 older adults from 35 general practic-
es in nine distinct areas in England participated at 
baseline, 2016–2018.
 ► OPAL participants are similar to those in general 
population of the same age.
 ► The cohort study relies on self- reported and rou-
tine National Health Service (NHS) data, there is not 
face- to- face data collection.
 ► Our findings may under represent older people living 
in the community with severe cognitive impairment.
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prevalence of chronic pain among older adults in the UK 
ranged from 42% in 65–74 years old to 62% in the over 
75 age group.9 These prevalence estimates are similar to 
other developed countries.10
Musculoskeletal pain has a large impact on many 
other aspects of older people’s health such as loss of 
mobility, frailty, cognitive impairment, falls and poor 
sleep quality.11–15 However, the role of musculoskeletal 
pain on adverse health outcomes in older adults is poorly 
understood. The majority of studies are cross- sectional 
in design, thus are limited; and only few longitudinal 
studies have examined potential mediators between pain 
and disability.16 A better understanding of the causal path 
between musculoskeletal pain and disability in represen-
tative community- based older adults is needed to inform 
decisions about treatment and rehabilitation.
There are a number of high- quality cohort studies 
examining age- related health conditions among 
community- dwelling older adults. These include the 
English Longitudinal Study of Ageing (ELSA), the Main-
tenance of Balance, Independent Living, Intellect, and 
Zest in the Elderly of Boston Study (MOBILIZE), the 
Longitudinal Study of Ageing, the Baltimore Longitu-
dinal Study of Aging and the Italian Invecchiare aging in 
Chianti Study (InChianti), among many others. However, 
to our knowledge, only one cohort focuses on the impact 
and contribution of musculoskeletal pain on disability in 
older people, the ongoing MOBILIZE Boston Study.17 
This American Cohort is limited by a relatively small 
sample size (765 participants at inception).
In order to address these knowledge gaps, we assembled 
the Oxford Pain, Activity and Lifestyle (OPAL) Cohort, 
a prospective study of community- dwelling older adults 
from across England. The immediate objectives were:
 ► To investigate the causes and consequences of 
mobility decline and disability in later life, and the 
role and contribution of musculoskeletal pain and 
other factors.
 ► To develop a prognostic tool to assess mobility decline 
in a population- based cohort of older adults in UK.
 ► To investigate factors that moderate or mediate the 
effects of musculoskeletal pain on health outcomes. 
For example, we will investigate whether specific 
social, physical and psychological factors play an 
intermediate role between low back pain and mobility 
decline.
In addition, we intend to use the OPAL Cohort to iden-
tify potential participants for future clinical trials of disa-
bility prevention in later life and to study disablement 
and multimorbidity more broadly. The ‘cohort multiple 
randomised controlled trials’ study design is becoming 
increasingly common.18 19 The concept is to use data 
collected from an established cohort to identify people 
with specific health conditions and then, as and when the 
opportunity arises, invite them to participate in a clinical 
trial relevant to their condition.
In this paper, we describe the OPAL Cohort, design, 
data collection, and the profile of study participants 
at baseline and their overall representativeness of the 
English general population.
COHORT DESCRIPTION
Study design
A population- based, longitudinal, prospective cohort 
study in England, using a combination of annually 
administered, self- reported questionnaires and routinely 
collected health data.
Practice and participant identification
General practice identification
General practices who were working with the National 
Institute for Health Research (NIHR) Clinical Research 
Network, which have been shown to be generalisable to 
wider primary care community,20 were approached to 
take part in the study. In terms of geographical spread, 
we included a range of rural and urban areas across 
England, to capture diversity in both socioeconomic and 
ethnic profiles.
Participant identification
Eligible participants were identified from electronic 
record searches of general practice lists. A random 
sample of approximately 400 individuals (median: 365; 
range 158–400) per practice was selected (figure 1). To 
ensure an equal representation in two age bands: 65–74 
and 75 years and over, around 200 individuals per prac-
tice within each age group were randomly selected.
Inclusion criteria
People registered with a general practice, aged 65 years 
and older, and living in the community, including shel-
tered or supported housing, were eligible for invitation.
Exclusion criteria
Individuals were excluded if they lived in a residen-
tial care or nursing home. Following the generation of 
the random sample, a designated general practitioner 
(GP) or research nurse from each practice screened 
the list to exclude those with known terminal illness 
with a life expectancy of less than 6 months, those who 
presented with severe health or social concerns sufficient 
to preclude approach, or those considered unable to 
provide informed consent.
Sample size
The sample size was determined by the prevalence of 
lower back pain and musculoskeletal problems in older 
people and driven by the sample size requirement for the 
prognostic tool to assess mobility decline. We prespec-
ified a minimum of 1000 participants of the sample 
should have lower back pain as this would be sufficient 
for a range of epidemiological analyses, including predic-
tive modelling, within subsample of people with lower 
back pain.21 22 The Cambridge Cohort Study of Ageing23 
provided the most recent estimates of disabling low back 
pain in the population aged 70–90 years, with prevalence 
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of 25%–30% for these age groups, respectively. If we 
assume that 25% of people aged over 65 years have low 
back pain, then we required a minimum of 4000 people 
to yield 1000 with low back pain and 3000 people without 
low back pain. We estimated that between 30% and 40% 
of participants would agree to participate based on uptake 
to the Prevention of Falls Injury Trial,24 which recruited 
an older population into an English falls prevention 
study and anticipated that there would be attrition from 
the sample over time. Therefore, we had to approach a 
minimum of 11 000 people, or approximately 350 people 
from each of 32 practices across our regions to achieve 
our recruitment target.
Recruitment and enrolment
Recruitment and enrolment to OPAL commenced in 
October 2016 and completed in September 2018. A 
total of 12 839 individuals from 35 general practices in 
9 different areas of England were invited to take part 
(figure 1). A pack including an invitation letter, partici-
pant information leaflet, consent form, baseline question-
naire and a postage paid return envelope was sent by the 
general practice. Five thousand four hundred and nine 
(42.1% of those eligible; range 5.1%–65.8% across prac-
tices) individuals who returned the baseline questionnaire 
and a signed consent form to the University of Oxford 
study office were enrolled in the study (figure 1). One- 
fifth (21.3% of those eligible; n=2736/12 839) declined 
participation and 4694 (36.6%; n=4694/12 839) did not 
respond. Non- responders were sent one postal reminder, 
4 weeks after the original invitation. If no response was 
received, no further contact was made. The flow chart of 
the sample is illustrated in online supplementary figure 
S1.
How often are participants followed up?
Study participants are followed up by postal question-
naire at annual intervals for 5 years. First year follow- up is 
completed, second and third year follow- up will complete 
in September 2020 and 2021, respectively. Future 
follow- up questionnaires will be sent at 4 and 5 years from 
the date of the original invitation.
What is being measured?
Postal self-completed questionnaire
The OPAL Cohort Study includes information on a range 
of domains including demographic, socioeconomic, life-
style variables, social participation, attitudes to ageing, 
musculoskeletal symptoms, health- related factors, comor-
bidity, mobility, disability, frailty, cognitive function, 
health- related quality of life (HRQoL) and medications 
(see table 1).
Musculoskeletal symptoms are assessed by asking the partic-
ipant if they have experienced any trouble (ache, pain or 
discomfort) in nine different body sites (knees, hands/
wrists, neck, shoulders, hips, feet/ankles, elbows, lower 
and upper back) during the last 6 weeks.25 26 Information 
on presence, frequency, troublesomeness, onset, and 
description of back pain in the last 6 weeks was collected 
using recognised methods.26–28 Information about the 
spread of back related symptoms was also included. To 
identify individuals with possible spinal stenosis we asked 
participants their pain travelled into their buttocks/legs, 
whether it was exacerbated while standing up or walking 
and whether the symptoms improved when sitting down 
or bending forward.29 30 Mobility was assessed using 
different measures. Confidence to walk a half a mile was 
assessed using a single item from the Modified Gait Self- 
efficacy Scale, which is rated on a 1 ‘not confident at all’ 
to 10 ‘totally confident’ scale.31 Participants also reported 
their perceived usual walking pace outdoors with six 
Figure 1 Locations of the areas from which the Oxford Pain, Activity and Lifestyle Cohort Study was derived. Map of England 
divided by counties.
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possible responses: ‘unable to walk’, ‘very slow’, ‘stroll at 
an easy pace’, ‘normal’, ‘fairly brisk’ and ‘fast’. Change 
in mobility in the last year was measured with the ques-
tion ‘Compared with 1 year ago, how would you rate your 
walking in general?’ (Response options: much better, 
somewhat better, about the same, somewhat worse or 
much worse than a year ago). Participant, family, friends 
or doctor’s concerns about participant ability to walk and 
move around were measured using two questions. Poten-
tial responses were ‘extremely’, ‘a little concerned’ or 
‘not concerned at all’. Life- space mobility was measured 
using five questions from the Life- Space Assessment 
(LSA) Questionnaire32: ‘During the past 4 weeks have you 
gone to: (1) other rooms in your home besides the room 
where you sleep? (2) An area outside of your home as 
your porch, deck or patio, hallway or garage? (3) Different 
places in your neighbourhood? (4) Locations outside of 
your neighbourhood, but within your city? And (5) Places 
outside your town?’ Falls data were collected as recom-
mended by the Prevention of Falls Network Europe, using 
a single question, ‘In the last 12 months, have you had 
any fall including a slip or trip following which you have 
come to rest on the ground, floor or lower level?’33 Three 
possible responses were available: not fallen, fallen once 
or more than once in the last year. Frailty was measured 
by The Tilburg Frailty Indicator,34 35 which is composed of 
two parts. The first part describes different determinants 
of frailty based on sociodemographic data and health- 
related questions. The second part contains 15 items, 
which measure three frailty domains: physical (8 items), 
psychological (4 items) and social (3 items). Frailty total 
scale and individual domain scores are derived from the 
second part. All items are rated as a binary response of 
either 0 or 1. Scores are the sum of the respective item 
points with a total score ranged from 0 to 15, with higher 
scores representing more frailty. A total score ≥5 points 
indicates that the individual is frail.34 Cognitive function 
was measured with a Clock- Drawing Test.36 Participants 
were asked to draw the entire face of a clock depicting 
the time ‘10 min after 11’ following the instructions 
given in the questionnaire. Scoring was a six- point system 
Table 1 Measures included in the OPAL Cohort Study
Data collection for the OPAL Cohort Study
Domain measured Self- reported measure Years (Y)
Sociodemographic Age, sex, education, relationship status Y0–Y5
Participation in clubs and groups54
Requires unpaid/paid carer
Ethnicity Y0
Number of live births and stillbirths
Socioeconomic Participant and GP area deprivation 
obtained from postcodes42
Y0–Y5
Current work status55
Type of housing
Adequacy of income56
Main occupation during lifetime57 
and self- rating of strenuousness of 
occupation
Y0
Internet access
Lifestyle Weight Y0–Y5
Alcohol and smoking58
Current physical activity59
Height Y0
Lifetime physical activity60
General health data Self- reported comorbidities and 
medication use
Y0–Y5
Sleep quality—Pittsburgh Sleep Quality 
Index61 and average number of hours 
sleep each night
Incontinence—2 items from Barthel 
Index62 63
Falls in the last 12 months33
Broken bones or fractures in the last 12 
months
Musculoskeletal 
symptoms
The Nordic Musculoskeletal 
Questionnaire adapted version25 26
Y0–Y5
Report of back pain in last 6 weeks, 
troublesomeness, onset of back pain 
and nature of back pain28
Y0–Y5
Leg pain and symptoms related to low 
back pain
Screening questions for neurogenic 
claudication29
Report of knee pain, troublesomeness, 
interference with daily activity64
Y1–Y2
Location of knee pain Y1
Mobility Change in mobility in the last year Y0–Y5
Self- rated walking speed65
Use of walking aids (inside and outside)
Mobility concerns
Access to transport54
Life- Space Assessment32
Single item from the Modified Gait Self- 
efficacy Scale (10- item)31
Difficulty with balance while walking Y2–Y5
Difficulties walking a half of mile66 Y3–Y5
Difficulties walking up and down a flight 
of stairs66
Continued
Data collection for the OPAL Cohort Study
Domain measured Self- reported measure Years (Y)
Disability Self- reported difficulty with activities of 
daily living (bathing, transfers, toilet use, 
dressing and eating)
Y2–Y5
Frailty Tilburg Frailty Index34 35 Y0–Y5
Cognition Clock- Drawing Test67 Y0–Y5
Beliefs about ageing Attitude to Ageing Questionnaire—
physical changes subscale68
Y0–Y5
Health- related quality 
of life
EuroQol 5- Dimension Health 
Questionnaire, five- level version37
Y0–Y5
EQ- VAS37
EQ- VAS, EuroQol Visual Analog Scale; GP, general practitioner; OPAL, Oxford Pain, 
Activity and Lifestyle.
Table 1 Continued
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according to visual- spatial aspects and the correct denota-
tion of time: normal cognition (score 6); minor visuospa-
tial errors (score 5); mild (score 4), moderate (score 3) 
or severe (score 2) visuospatial disorganisation of time, or 
no reasonable representation of a clock (score 1).
HRQoL was measured by the EuroQol- 5D- 5L (EQ- 5D- 5L) 
Questionnaire, a generic measure of HRQoL that includes 
five levels of functioning from level 1 (no problems) to 
level 5 (severe or extreme problems).37 38 Additionally, 
respondents rated their current health status according to 
the EuroQol Visual Analog Scale (EQ- VAS), from 0 (worst 
imaginable health) to 100 (best imaginable health). The 
responses from the five domains were converted into a 
single EQ- 5D Index Value using the EQ- 5D- 5L Crosswalk 
Index Value Calculator to produce a final QoL Value.39 40 
The index values ranged between −0.594 (a state worse 
than death) and 1 (best possible health state).
New variables have been added to follow- up question-
naires (table 1), allowing the cohort to be used for a 
wider range of analytical approaches and purposes, and 
to dovetail to recruitment of new clinical trials. The first 
follow- up (Year 1) repeated baseline variables (table 1) 
with the exception of ethnicity, number of children, 
height, education, lifetime physical activity, main occupa-
tion during lifetime, self- rating of strenuousness of occu-
pation and use of smartphone or computer to access the 
internet. Added variables included presence, frequency, 
troublesome, location and description of knee pain. The 
second wave of follow- up of data collection is collecting 
variables included in previous wave (Year 1) in addition to 
difficulty balancing while walking and any difficulty in the 
following basic activities of daily living; bathing, transfers, 
toilet use, dressing and eating. Each activity will be rated 
from ‘no difficulty’ to ‘unable to perform’.
Characteristics of participating general practices
General practice deprivation and estimated proportion 
of non- white ethnic groups in the practice population 
were obtained from Public Health England (PHE).41 
Deprivation was measured by the Index of Multiple 
Deprivation 2015 (IMD 2015).42 Practice IMD scores are 
practice population weighted based on the Lower Layer 
Super Output Areas (LSOAs) where the practice popula-
tion resides. LSOA is a low- level geography designed to 
contain 1500 inhabitants on average. Following the 2011 
census, there were 32 844 English LSOAs.
General practice urbanity was defined using the 2011 
urban–rural classification.43 Within this classification, any 
settlement with a population of 10 000 people or more is 
defined as urban, with all others are classified as rural. It 
was determined at the LSOA level. Each general practice 
postcode was linked to its LSOA and it was then matched 
to urbanity.44
Data management and quality control
All data are being processed and stored according to the 
Data Protection Act 2018. As the OPAL Study predated 
General Data Protection Regulation (GDPR) 2018, all 
participants were sent an updated GDPR statement along 
with their next annual questionnaire.
A software application was developed to support the 
filtering and random sampling of individuals from the 
practice lists. Identifiable data were removed by the appli-
cation. When eligible participants were selected, a unique 
screening number was allocated to each participant and 
given to the practice. Each general practice put invitation 
letters into the corresponding prenumbered participant 
pack and completed the mail out.
The study office in Oxford receives returned question-
naires and the coordinating team undertake data quality 
checks. Returned questionnaires are processed using the 
electronic data capture software TeleForm Workgroup 
(Serial Number: 247885; Company name: ePartner 
Consulting), which includes internal system validation 
checks. Once questionnaires are scanned, additional vali-
dation is manually completed by a member of the OPAL 
Study team. For example, if a questionnaire is returned 
with a double- page spread missing, the participant is 
contacted by telephone with a maximum of two attempts 
(on 2 separate days) to complete missing sections.
Access to electronic linkage
The majority of OPAL participants (99.2% of those who 
agreed to participate; n=5367/5409) consented for the 
research team access their UK National Health Service 
(NHS) Digital and primary healthcare records, and to be 
approached for future interventional and observational 
studies (up to date, data linkage are not completed). 
NHS Digital is a national provider of information, data 
and information technology systems for commissioners, 
analysts and clinicians in health and social care. The data-
base holds information on hospital admissions, outpatient 
and accident and emergency department visits for indi-
viduals receiving NHS hospital treatment in England.45 
Diagnoses are coded using WHO’s International Classi-
fication of Disease V.10. In addition, date and cause of 
death will be purchased/linked to NHS Digital.
Patient and public involvement statement
Patients and the public were involved in the development 
of the research question, the design of the study and 
the conduct of the research. We piloted and refined the 
OPAL Cohort Study questionnaires with our Patient and 
Public Involvement (PPI) representatives. Our PPI group 
included older adults for whom English was a second 
language in order to ensure acceptability of wording of 
materials and to assist with uptake of the study by ethnic 
minority groups. We will continue to collaborate with our 
PPI representatives when drafting publications and with 
dissemination of findings to patients and the public.
Statistical analysis
Descriptive statistics were used to summarise demographic 
and health- related measures of the OPAL participants at 
baseline. Selected key demographic and health- related 
variables are reported in this manuscript.
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To assess whether our cohort is representative of the 
population of England, we compared a range of demo-
graphic and health- related characteristics of the OPAL 
Cohort Study with the 2011 England Census46 and with 
The ELSA Cohort.47 We deliberately focus on absolute 
differences and not on statistical significance because the 
large study samples may produce low p values even when 
absolute differences are small. Analyses were performed 
using STATA software V.15.1 (StataCorp).
The English Longitudinal Study of Ageing
The ELSA Study is an ongoing prospective cohort study 
of a representative sample of community- dwelling people 
aged 50 years or older living in England.47 It started 
in 2002 (wave 1), with participants recruited from an 
annual cross- sectional survey of households who were 
then followed up every 2 years. For this comparison, we 
used cross- sectional ELSA data from the core members 
(n=7223) at wave 8 (May 2016 to June 2017), as the time 
period was comparable with the OPAL Study on recruit-
ment. ELSA participants aged <65 years (n=2102) and 
institutionalised (n=56) were excluded for the compar-
ison. Thus, data from 5065 ELSA participants were 
included.
We compared the following participant characteris-
tics between ELSA and OPAL: work status (retired vs 
non- retired), current relationship status (married vs 
non- married), weight, smoking status and health- related 
self- reported doctor- diagnosed chronic diseases (arthritis, 
diabetes, heart problems, stroke, dementia, lung disease, 
osteoporosis and high blood pressure).48 We applied the 
recommended weightings to the data to correct for non- 
response in ELSA Cohort Study.49
Further details of the variables used in OPAL and ELSA 
Cohort Studies are described in online supplementary 
table S1. The ELSA data management is available in a 
Stata do- file ‘online supplementary Data_management_
wave8_Dec2019’ in supplementary information. The 
measurement protocol for the ELSA Cohort Study can be 
found online (http://www. ifs. org. uk/ elsa).
Dealing with missing data
Bias due to missing data (and the mechanism causing the 
data to be missing) will be investigated and an appropriate 
analysis approach, such as multiple imputation and/or 
inverse- probability weighting, to manage this problem 
will be used depending on the type of study being anal-
ysed. Only observed characteristics of OPAL participants 
at baseline are shown in this manuscript.
FINDINGS TO DATE
Response to invitation to participate
A total of 8145 individuals (63.4% among the 12 839 
eligible participants) who were sent the invitation letter 
responded to the invitation, 5409 individuals (66.4% 
among the 8145 responders) agreed to participate in the 
study and 2736 individuals declined to participated (see 
online supplementary figure S1).
Age and sex distribution of participants and non- 
participants (declined and non- responders) are shown 
in online supplementary table S2, and by general prac-
tice in online supplementary figures S2 and S3. Overall, 
the participation rate in the OPAL Cohort Study was 
lower in the oldest age group (participation rates were 
over 44% for those aged 65–79 years and 36% for those 
aged 80+ years, respectively), although these were within 
the expected response rate. Response rate was similar 
between sexes (participation rates were 44.2% and 42.8% 
in men and women, respectively). No differences between 
participants and non- participants in terms of age or sex 
were observed, and these results were consistent across 
most practices.
Questionnaire response rate (among eligible individ-
uals) by practice ranged from 5.1% to 65.8% (median: 
45.6%; IQR: 32.2%–54.3%). Lower levels of response 
were observed in the most deprived practices (see online 
supplementary table S3).
OPAL baseline data have a low proportion of missing 
values. The amount of missing data for any single variable 
varied from 0.2% (n=13/5409) (for relationship status 
and current work status) to 5.9% (n=321/5409) (for 
Tilburg Frailty Score (0–15); item missing ranging from 
0.4% to 1.9%).
Characteristics of OPAL Study participants at baseline
The demographic characteristics of participants are 
reported in table 2. Half of the participants were women 
(51.5%; n=2784/5409), and the mean (SD) age was 74.9 
(6.8) years, ranging from 65 to 100 years. The majority of 
study participants were white (94.9%; n=5132/5409).
The majority of participants were married or part-
nered (66.6%; n=3602/5409), with a higher proportion 
of women living alone. Most participants were retired 
(84.8%; n=4589/5409), and had secondary school educa-
tion (56.4%; n=3051/5409). The median (IQR) area 
deprivation score of participants was 12.5 (6.9–20.3) and 
it was similar between sexes. In England, the median 
(IQR) deprivation score is 17.4 (9.7–30.1). Women were 
less likely to report that they were current smokers or 
drinking alcoholic beverages at least once every week 
than men. The prevalence of overweight (Body Mass 
Index (BMI): 25–29.9 kg/m2) and obesity (BMI: ≥30 kg/
m2) among the whole sample was 38.1% (n=2061/5409) 
and 18.6% (n=1005/5409), respectively.
Health- related variables of men and women are 
described in table 3 and figure 2. A high proportion 
of OPAL participants (84.0%; n=4543/5409) reported 
musculoskeletal symptoms in at least one body area in the 
previous 6 weeks, with symptoms being more prevalent in 
women than men (table 3). Low back pain was the most 
frequently reported site for pain (44.4%; n=2404/5409).
The majority of participants were mobile and were 
confident to walk half a mile (66.1%; n=3577/5409), with 
a higher proportion of men being confident walkers. 
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Over one- third (38.7%; n=2094/5409) of participants 
rated their walking speed as strolling at an easy pace or 
very slow, 18.5% (n=1002/5409) reported using a walking 
aid inside or outside and 25.5% (n=1375/5409) reported 
Table 2 Sociodemographic and life- style factors of men 
and women in the OPAL Cohort Study
Characteristic
Men
(n=2625)
Women
(n=2784)
Age, mean (SD) 74.8 (6.7) 75.0 (6.8)
Age groups, n (%)
  65–69 784 (29.9) 801 (28.8)
  70–74 696 (26.5) 734 (26.4)
  75–79 542 (20.7) 618 (22.2)
  80–84 355 (13.5) 356 (12.8)
  85–89 196 (7.5) 203 (7.3)
  90+ 52 (2.0) 72 (2.6)
Ethnicity (white), n (%) 2465 (93.9) 2667 (95.8)
Relationship status, n (%)
  Married/civil union 1897 (72.3) 1506 (54.1)
  Living with partner 114 (4.3) 85 (3.1)
  Unmarried (never married) 117 (4.5) 105 (3.8)
  Separated/divorced 185 (7.1) 273 (9.8)
  Widow/widower 305 (11.6) 809 (29.1)
Live alone, n (%) 534 (20.3) 1021 (36.7)
Education, n (%)
  High professional or 
university
1017 (38.7) 895 (32.2)
  Secondary school only 1370 (52.2) 1681 (60.4)
  None or primary 219 (8.3) 189 (6.8)
Work status (retired), n (%) 2187 (83.3) 2402 (86.3)
Quintiles of IMD, n (%)
  Q1—Most deprived 293 (11.2) 289 (10.4)
  Q2 323 (12.3) 339 (12.2)
  Q3 542 (20.7) 613 (22.0)
  Q4 575 (21.9) 591 (21.2)
  Q5—Least deprived 892 (34.0) 952 (34.2)
BMI (kg/m2), mean (SD) 26.8 (4.3) 26.4 (5.3)
Smoking status, n (%)
  Never 1071 (40.8) 1618 (58.1)
  Ex- smoker 1401 (53.4) 1040 (37.4)
  Current 145 (5.5) 118 (4.2)
Cigarettes per day, median 
(IQR)
15 (10–20) 10 (5–17)
Alcohol intake once per 
week, n (%)
1861 (70.9) 1361 (48.9)
Data included older adults 65 years and older at baseline 2016–
2018.
BMI, Body Mass Index; IMD, Index of Multiple Deprivation; OPAL, 
Oxford Pain, Activity and Lifestyle.
Table 3 Health- related characteristics of men and women 
at the OPAL Cohort Study
Health- related 
characteristics
Men
(n=2625)
Women
(n=2784)
Musculoskeletal symptoms in the last 6 weeks, n (%)
  Low back (small of 
the back)
1098 (41.8) 1306 (46.9)
  One of both knees 932 (35.5) 1132 (40.7)
  Wrist/hands 653 (24.9) 1053 (37.8)
  Neck 673 (25.6) 951 (34.2)
  Shoulders 667 (25.4) 948 (34.1)
  One of both hips/
thighs
599 (22.8) 875 (31.4)
  One or both ankles/
feet
559 (21.3) 755 (27.1)
  Upper back 160 (6.1) 346 (12.4)
  Elbows 161 (6.1) 173 (6.2)
Any pain, n (%) 2137 (81.4) 2406 (86.4)
Mobility
Confidence to walk 
half a mile, median 
(IQR)
10 (9–10) 10 (6–10)
Outdoor walking pace, n (%)
  Fast 91 (3.5) 93 (3.3)
  Fairly brisk 534 (20.3) 572 (20.6)
  Normal 994 (37.9) 958 (34.4)
  Stroll at an easy 
pace
647 (24.7) 726 (26.1)
  Very slow 326 (12.4) 395 (14.2)
  Unable to walk 19 (0.7) 27 (1.0)
Walking rate than 1 year ago, n (%)
  Much better 52 (2.0) 84 (3.0)
  Somewhat better 114 (4.3) 101 (3.6)
  About the same 1822 (69.4) 1831 (65.8)
  Somewhat worse 507 (19.3) 622 (22.3)
  Much worse 113 (4.3) 133 (4.8)
Walking aid use inside 
(yes), n (%)
108 (4.1) 153 (5.5)
Walking aid use 
outside (yes), n (%)
306 (11.7) 435 (15.6)
Falls in the last year, n (%)
  None 1900 (72.4) 1906 (68.5)
  One fall 474 (18.1) 624 (22.4)
  More than one fall 235 (9.0) 236 (8.5)
Frailty, Tilburg Frailty 
Score, median (IQR)
2 (1–4) 3 (1–5)
Clock- Drawing Test, n (%)
  1 point 9 (0.3) 5 (0.2)
  2 points 28 (1.1) 45 (1.6)
  3 points 112 (4.3) 102 (3.7)
  4 points 210 (8.0) 273 (9.8)
Continued
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that their walking speed to be slower than a year ago. Over 
a quarter of participants (29.0%; n=1569/5409) reported 
having fallen once or more in the 12 months prior to the 
baseline questionnaire, and 27.1% (n=1463/5409) were 
classified as frail. Frailty was more prevalent in women. 
The majority of study participants presented high cogni-
tive function, with 82.8% (n=4481/5409) of participants 
having a score of 5 or 6 points in the Clock- Drawing 
Test. Most of the participants reported good health 
across four domains of the EQ- 5D- 5L questions with 
88.5% (n=4784/5409), 69.7% (n=3772/5409), 66.1% 
(n=3577/5409) and 59.0% (n=3190/5409) reporting no 
problems with self- care, anxiety/depression, usual activi-
ties and mobility, respectively, except for pain/discomfort 
with a percentage of participants reporting no problems 
of 29.5% (n=1594/5409). The average HRQoL measured 
by EQ- 5D- 5L Crosswalk Value set and the EQ- VAS were 
0.79 (SD 0.20) and 78.4 (SD 17.4), respectively. Women 
reported worse HRQoL (lower average score in both 
scales) compared with men (table 3). The average self- 
reported EQ- VAS Score in population norms for UK 
population aged 65–74 and 75 years and over50 is broadly 
comparable with the OPAL Study (population norm vs 
OPAL Study: 77.3 vs 80.5 and 73.8 vs 75.6, respectively).
The more frequently self- reported health condition 
was high blood pressure (45.5%; n=2459/5409), followed 
by arthritis (44.2%; n=2391/5409) and angina or heart 
problems (20.2%; n=1094/5409). High blood pressure 
was the most prevalent condition among men (47.4%; 
n=1244/2625), and arthritis the most prevalent in women 
(52.3%; 1455/2784) (figure 2).
Representativeness of OPAL Cohort Study
Demographic characteristics in OPAL Cohort Study were 
similar to the general population of the same age range 
in the 2011 England Census (see online supplementary 
table S4). There was a lower proportion of women in the 
80 and older age group in OPAL Study compared with 
the general population.
Online supplementary tables S5 and S6 show the sex- 
specific distribution of health- related characteristics in 
OPAL and ELSA Cohort Studies across four age groups. 
Overall, health- related characteristics of the OPAL partic-
ipants were broadly comparable with those recruited to 
the nationally representative ELSA Cohort Study.
Both men and women participants in the OPAL Study 
were less likely to smoke and had a lower prevalence of 
self- reported heart problems, stroke and dementia.
Characteristics of included general practices
General practice area deprivation and the estimated 
proportion of ethnic groups registered in the practice 
population are described in online supplementary table 
S3. Of the 35 general practices included in the study, 
32 had data available on PHE national general prac-
tice profiles website. Overall, 9 of 32 practices (28.1%) 
were classified among the most deprived practices (IMD 
deciles 1–3), 14 of 32 (43.8%) in the most affluent prac-
tices (IMD deciles 8–10) and the remainder categorised 
as moderate (n=9/32; 28.1%; IMD deciles 4–7).
Over 14.3% (n=5/35) of general practices are located 
in rural areas, a slightly lower proportion than across 
rural areas in England as a whole (17.0%; n=5598/32 844 
LSOAs).
Cohort multiple randomised controlled trial
The first registered randomised controlled trial using 
the OPAL Cohort Study is now being undertaken. This 
NIHR- funded trial is testing the effectiveness of a physio-
therapist delivered combined physical and psychological 
intervention for older adults with neurogenic claudi-
cation compared with best practice advice (BOOST).51 
The trial is registered with the International Standard 
Randomised Controlled Trials Database, reference 
number ISRCTN12698674.
STRENGTHS AND LIMITATIONS
The original target for recruitment of the OPAL Cohort 
Study was a minimum of 4000 older adults from 32 general 
practices. However, uptake was better than predicted and 
we have recruited 5409 older adults from 35 general prac-
tices within 9 distinct areas, providing good geographical 
coverage within England. The wide range of self- report 
health measures will allow us to account for a large range 
of potential mediating and confounding variables.
Health- related 
characteristics
Men
(n=2625)
Women
(n=2784)
  5 points 445 (17.0) 487 (17.5)
  6 points 1756 (66.9) 1793 (64.4)
Quality of life
  EQ- 5D Crosswalk 
Index Value, mean 
(SD)
0.79 (0.19) 0.76 (0.21)
  EQ- VAS, mean (SD) 79.1 (16.7) 77.7 (18.0)
Sample sizes may vary due to missing values; data included 
older adults 65 years and older at baseline 2016–2018.
EQ- VAS, EuroQol Visual Analog Scale; IQR, Interquartile Range; 
OPAL, Oxford Pain, Activity and Lifestyle.
Table 3 Continued
Figure 2 Health conditions in men and women of Oxford 
Pain, Activity and Lifestyle Cohort Study.
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One important limitation of the cohort is the reliance 
on self- reported data. We acknowledge that performance 
tests may provide more reliable objective data; however, 
we were interested in patient reported factors and 
outcomes as these are feasible to capture during a patient 
consultation and findings may be applied within clinical 
practice. We also have obtained written informed consent 
to access NHS Digital and primary healthcare data for the 
majority of the participants, to allow independent veri-
fication of diagnoses related to hospital admission and 
attendance, and as well as important elements of health 
service resource use and mortality. Biological markers are 
not systematically collected in electronic health records 
and this may be a potential weaknesses. However, the 
OPAL Cohort Study was designed to elucidate the epide-
miology of musculoskeletal pain and the contribution of 
pain on health- related outcomes rather than attempt to 
investigate the biological underpinning of musculoskel-
etal pain.
Individuals living in more deprived neighbourhoods 
(based on practice population deprivation) and non- 
white ethnicity groups were less likely to participate in 
OPAL (see online supplementary table S3). This finding 
is consistent with other epidemiological studies which 
report that populations with a lower socioeconomic posi-
tion are less likely to take part in research compared 
with those with higher socioeconomic position.52 Never-
theless, our population is broadly representative of the 
English population.
Our findings will apply to community- dwelling older 
adults in England and may under represent those living 
in the community with severe cognitive impairment.
In terms of the representativeness of the OPAL Study, 
demographic and health- related characteristics of OPAL 
participants are similar to those in the general popula-
tion (2011 Census) and ELSA Study, respectively, (see 
online supplementary tables S4–S6). The selected vari-
ables for the comparison analysis had good comparability 
in both OPAL and ELSA Studies, but there were some 
differences. For example, in ELSA, weight was calculated 
using measured weight, whereas in OPAL weight was self- 
reported. Self- reported weight tends to be underreported, 
particularly by women and those who are heaviest.53 In 
addition, in ELSA, the definition of ‘smoker status’ and 
health conditions combines information from previous 
waves, whereas in OPAL Study, only baseline informa-
tion was used. This may have led to a slight underestima-
tion of the difference between ELSA and OPAL in the 
percentage of ‘ex- smoker’ and individuals with the health 
condition.
FUTURE WORK
Data collection for the Year 1 Follow- up Questionnaire 
was completed in September 2019 and Year 2 and 3 
Follow- up Questionnaires will be completed in 2020 and 
2021, respectively. We plan to administer questionnaires at 
annual intervals, and aim to continue this for a minimum 
of 5 years.
The potential of this data set has yet to be exploited 
and further work is in progress. We will start focusing 
on particular health domains (such as low back pain 
and mobility problems), together with an exploration of 
factors underlying the variability of those health domains. 
For example, we will investigate whether social, physical 
and psychological factors mediate the effect between low 
back pain and immobility. Future work will include the 
development of a prognostic tool to identify older adults at 
risk of mobility decline to help individuals, GPs and other 
health professionals identify risk factors and when these 
should be prioritised as a treatment target. This longitu-
dinal cohort study will also identify health trajectories and 
will examine their associations with demographic, clinical 
and social factors, with the aim of identifying factors that 
maintain good health and independence in older people.
COLLABORATION
We welcome potential collaborations with other research 
groups. Interested researchers should contact Professor 
Sarah (Sallie) Lamb ( S. E. Lamb@ exeter. ac. uk/ sarah. 
lamb@ ndorms. ox. ac. uk) to discuss collaboration. Further 
information on the OPAL Cohort Study can be found on 
our website (http://www. ndorms. ox. ac. uk/ rrio/ opal).
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